LGVN experienced severe financial deterioration with cash plummeting 76% to $4.7M while R&D expenses surged 48% and losses deepened 42%.
The company faces immediate liquidity concerns as cash burned from $19.2M to $4.7M while operating losses widened significantly to $22.7M annually. With current liabilities increasing 58% and minimal revenue generation, LGVN appears to be approaching a critical funding inflection point that could force dilutive equity raises or operational restructuring.
LGVN's financial position deteriorated dramatically across all key metrics, with cash and total assets declining approximately 60-76% while losses expanded substantially. Revenue dropped 42% to just $709K while R&D spending increased 48% to $12M, creating an unsustainable burn rate that decimated the balance sheet. The combination of rising liabilities, shrinking assets, and accelerating losses signals acute financial distress requiring immediate capital infusion to maintain operations.
Cash declined 75.8% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
Current assets declined 72.2% — monitor working capital adequacy and short-term liquidity.
Capex reduced 62.6% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Total assets contracted 59.9% — asset sales, write-downs, or balance sheet optimization underway.
Current liabilities surged 58.3% — significant near-term obligations; verify ability to meet short-term debt.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
R&D investment increased 48% — signals commitment to future product development, though near-term margin impact.
Net income declined 42.1% — review whether driven by operations, interest costs, or non-recurring items.
Revenue declined 42% — significant demand weakness or market share loss warrants investigation.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →